Conventional stents versus stents loaded with 125iodine seeds for the treatment of unresectable oesophageal cancer: A multicentre, randomised phase 3 trial

The Lancet Oncology

Volumn 15, Issue 6, 2014, Pages 612-619

  Zhu, Hai Dong ^a   Guo, Jin He ^a   Mao, Ai Wu ^b   Lv, Wei Fu ^c   Ji, Jian Song ^d   Wang, Wen Hui ^e   Lv, Bin ^f   Yang, Rui Min ^g   Wu, Wei ^h   Ni, Cai Fang ⁱ   Min, Jie ^j   Zhu, Guang Yu ^a   Chen, Li ^a   Zhu, Mei Ling ^k   Dai, Zhen Yu ^l   Liu, Peng Fei ^m   Gu, Jian Ping ⁿ   Ren, Wei Xin ^o   Shi, Rui Hua ⁿ   Xu, Gao Feng ^p   He, Shi Cheng ^a   Deng, Gang ^a   Teng, Gao Jun ^a   more..

^a AFFILIATED ZHONGDA HOSPITAL OF SOUTHEAST UNIVERSITY   (China)

^b Shanghai St Luke's Hospital   (China)

^c ANHUI PROVINCIAL HOSPITAL   (China)

^d LISHUI CENTRAL HOSPITAL   (China)

^e LANZHOU UNIVERSITY   (China)

^f Zhejiang Hospital of Traditional Chinese Medicine   (China)

^g XINXIANG MEDICAL UNIVERSITY   (China)

^h THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

ⁱ THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^j SOUTHEAST UNIVERSITY   (China)

^k THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^l The Sixth Affiliated Hospital of Nantong University   (China)

^m JIANGYIN PEOPLE S HOSPITAL   (China)

ⁿ THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^o XINJIANG MEDICAL UNIVERSITY   (China)

^p Yancheng First People's Hospital   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125;

ADULT; ARTICLE; ASPIRATION PNEUMONIA; BLEEDING; BRACHYTHERAPY; CANCER SURVIVAL; CHINA; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG COATING; DRUG EFFICACY; DYSPHAGIA; ESOPHAGEAL STENT; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SINGLE BLIND PROCEDURE; SURVIVAL TIME; THORAX PAIN; TRACHEOESOPHAGEAL FISTULA; TREATMENT RESPONSE;

ADENOCARCINOMA; AGED; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IODINE RADIOISOTOPES; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SINGLE-BLIND METHOD; STENTS;

EID: 84899935264     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(14)70131-7     Document Type: Article

References (30)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Enzinger PC, Mayer RJ Esophageal cancer. N Engl J Med 2003, 349:2241-2252.
3. Pennathur A, Gibson MK, Jobe BA, Luketich JD Oesophageal carcinoma. Lancet 2013, 381:400-412.
4. Mariette C, Piessen G, Triboulet JP Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol 2007, 8:545-553.
5. Polednak AP Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas. Int J Cancer 2003, 105:98-100.
6. Cavallin F, Scarpa M, Cagol M, Alfieri R, Castoro C What is the optimal management of dysphagia in metastatic esophageal cancer?. Current oncology (Toronto, Ont) 2012, 19:e501.
7. Song HY, Do YS, Han YM, et al. Covered, expandable esophageal metallic stent tubes: experiences in 119 patients. Radiology 1994, 193:689-695.
8. Hindy P, Hong J, Lam-Tsai Y, Gress F A comprehensive review of esophageal stents. Gastroenterol Hepatol 2012, 8:526-534.
9. Homs MY, Steyerberg EW, Eijkenboom WM, et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet 2004, 364:1497-1504.
10. Bergquist H, Johnsson E, Nyman J, et al. Combined stent insertion and single high-dose brachytherapy in patients with advanced esophageal cancer-results of a prospective safety study. Dis Esophagus 2012, 25:410-415.
11. Guo JH, Teng GJ, Zhu GY, He SC, Deng G, He J Self-expandable stent loaded with 125I seeds: feasibility and safety in a rabbit model. Eur J Radiol 2007, 61:356-361.
12. Guo JH, Teng GJ, Zhu GY, et al. Self-expandable esophageal stent loaded with 125I seeds: initial experience in patients with advanced esophageal cancer. Radiology 2008, 247:574-581.
13. Ogilvie AL, Dronfield MW, Ferguson R, Atkinson M Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy. Gut 1982, 23:1060-1067.
14. Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources. A report of ICRP Publication 98. Ann ICRP 2005, 35:iii-vi. International Commission on Radiological Protection, 3-50.
15. White RE, Parker RK, Fitzwater JW, Kasepoi Z, Topazian M Stents as sole therapy for oesophageal cancer: a prospective analysis of outcomes after placement. Lancet Oncol 2009, 10:240-246.
16. Shridhar R, Almhanna K, Meredith KL, et al. Radiation therapy and esophageal cancer. Cancer Control 2013, 20:97-110.
17. Liu H, Wang Q, Jia X, Liu B, Wang CK Early-stage esophageal squamous cell carcinoma treated with californium-252 neutron brachytherapy: clinical report on 16 cases. Tumori 2013, 99:172-175.
18. Homs MY, Essink-Bot ML, Borsboom GJ, Steyerberg EW, Siersema PD Quality of life after palliative treatment for oesophageal carcinoma-a prospective comparison between stent placement and single dose brachytherapy. Eur J Cancer 2004, 40:1862-1871. Dutch SIREC Study Group.
19. Amdal CD, Jacobsen AB, Guren MG, Bjordal K Patient-reported outcomes evaluating palliative radiotherapy and chemotherapy in patients with oesophageal cancer: a systematic review. Acta Oncol 2013, 52:679-690.
20. Agranovich A, McGahan CE, Gurjal A Long-term survivorship of esophageal cancer patients treated with radical intent. Can J Gastroenterol 2008, 22:393-398.
21. Polinder S, Homs MY, Siersema PD, Steyerberg EW Cost study of metal stent placement vs single-dose brachytherapy in the palliative treatment of oesophageal cancer. Br J Cancer 2004, 90:2067-2072.
22. Bergquist H, Wenger U, Johnsson E, et al. Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial. Dis Esophagus 2005, 18:131-139.
23. Dai Z, Zhou D, Hu J, et al. Clinical application of iodine-eluting stent in patients with advanced esophageal cancer. Oncol Lett 2013, 6:713-718.
24. Palesty JA, Dudrick SJ What we have learned about cachexia in gastrointestinal cancer. Dig Dis 2003, 21:198-213.
25. Langius JA, Bakker S, Rietveld DH, et al. Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy. Br J Cancer 2013, 109:1093-1099.
26. Gray RT, O'Donnell ME, Scott RD, McGuigan JA, Mainie I Impact of nutritional factors on survival in patients with inoperable oesophageal cancer undergoing self-expanding metal stent insertion. Eur J Gastroenterol Hepatol 2011, 23:455-460.
27. Zhongmin W, Xunbo H, Jun C, et al. Intraluminal radioactive stent compared with covered stent alone for the treatment of malignant esophageal stricture. Cardiovasc Intervent Radiol 2012, 35:351-358.
28. Sabharwal T, Morales JP, Salter R, Adam A Esophageal cancer: self-expanding metallic stents. Abdom Imaging 2005, 30:456-464.
29. Shimi SM Self-expanding metallic stents in the management of advanced esophageal cancer: a review. Semin Laparosc Surg 2000, 7:9-21.
30. Didden P, Spaander MC, Bruno MJ, Kuipers EJ Esophageal stents in malignant and benign disorders. Curr Gastroenterol Rep 2013, 15:319.